SCHEMBL24735262

SCHEMBL24735262

Bc1c(B)c(B)c(-c2c3ccccc3c(-c3cccc4oc5cc6ccccc6cc5c34)c3ccccc23)c(B)c1B

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.32
HPGD P15428 4/20 0.32
HSD17B10 Q99714 3/20 0.32
TSHR P16473 2/20 0.32
MAPK1 P28482 2/20 0.32
CASP1 P29466 2/20 0.32
HIF1A Q16665 2/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
TP53 P04637 1/20 0.32
CASP7 P55210 1/20 0.32
XRCC6 P12956 1/20 0.32
XRCC5 P13010 1/20 0.32
PRKDC P78527 1/20 0.32
CES1 P23141 1/20 0.31
AHR P35869 2/20 0.31
KDM4E B2RXH2 2/20 0.31
MAPT P10636 2/20 0.31
GAA P10253 1/20 0.31
NTRK1 P04629 1/20 0.31
PLK3 Q9H4B4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24454780 0.87 AHR (0.39) ALDH1A1HPGDHSD17B10TSHRMAPK1
SCHEMBL23814319 0.86 XRCC6 (0.30) ALDH1A1HPGDHSD17B10TSHRMAPK1
SCHEMBL17931897 0.85 PSD (0.40) ALDH1A1HPGDHSD17B10TSHRMAPK1
SCHEMBL26592714 0.85
SCHEMBL24776860 0.85 ALDH1A1 (0.31) ALDH1A1HPGDHSD17B10TSHRMAPK1
SCHEMBL23943273 0.85 HPGD (0.32) ALDH1A1HPGDHSD17B10TSHRMAPK1
SCHEMBL24663086 0.84 CES1 (0.45) ALDH1A1HPGDHSD17B10TSHRMAPK1
SCHEMBL24454773 0.83 ALDH1A1 (0.37) ALDH1A1HPGDHSD17B10TSHRMAPK1
SCHEMBL24663135 0.83 MAOA (0.36) ALDH1A1HPGDHSD17B10TSHRMAPK1
SCHEMBL23758588 0.83 ALDH1A1 (0.44) ALDH1A1HPGDHSD17B10TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240023426-A1 ORGANIC ELECTROLUMINESCENT ELEMENT, ORGANIC ELECTROLUMINESCENT LIGHT EMITTING APPARATUS, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 US disclosed
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2024-01-18 US disclosed
US-20220393110-A1 ORGANIC ELECTROLUMINESCENCE ELEMENT, COMPOSITION, POWDER, ELECTRONIC EQUIPMENT, AND NOVEL COMPOUND IDEMITSU KOSAN CO.,LTD. (CN) 2022-12-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240023436-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE EED, EML4, ESR1 ALDH1A1 1141/4885HPGD 2774/4885HSD17B10 1678/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.